Portfolio

Meneillään olevat projektit

Oncology

MTAP-deleted cancers

Kohde Pharma Oy

Seed investment

Next stage: Hit identification

Oncology

Cancer drug resistance

University of Turku

Co-development

Next stage: Hit identification

Multiple

Novel small GTPase

University of Eastern Finland

Proof-of-idea

Next stage: Hit identification

Multiple

NRF2 inhibitor

University of Eastern Finland

Proof-of-idea

Next stage: Hit identification

Multiple

First-in-Class PARP Inhibitors, R2B

University of Oulu

Consulting

Next stage: Lead optimization